@article{bruen_impact_nodate,
	title = {The {Impact} of {Reimbursement} {Policies} and {Practices} on {Healthcare} {Technology} {Innovation}},
	abstract = {Methods \& Analytical FrameWork................................................................................................................ 4 Defining Key Terms ................................................................................................................................... 4 Development of an Analytic Framework .................................................................................................. 8 Analysis of Key Characteristics of Reimbursement Methods ................................................................... 8 Expert Consultations................................................................................................................................. 9 Case Studies .............................................................................................................................................. 9
Results......................................................................................................................................................... 11 Tracing the Link from Reimbursement to Innovation............................................................................. 12 Key Characteristics of Reimbursement Methods ................................................................................... 13 How Reimbursement Characteristics Affect Components of ROI and Incentives to Innovate .............. 22 The Reimbursement Decision-Making Process................................................................................... 22 Product Categorization and Differentiation........................................................................................ 29 Method of Payment............................................................................................................................ 36 Defining the Payment Amount ........................................................................................................... 41 Patient Cost Sharing............................................................................................................................ 47
Conclusion................................................................................................................................................... 54 Suggestions for Future Research ........................................................................................................ 57 Appendix A: A Standard Reimbursement Decision-Making Process .......................................................... 60 Appendix B: hi HealthInnovations Case Study............................................................................................ 62 Appendix C: Premera Value-Based Formulary Case Study ......................................................................... 72 Appendix D: NICE (UK) Performance-Based Reimbursement for Velcade® ............................................... 83 Appendix E: Expert Panelists....................................................................................................................... 93},
	language = {en},
	author = {Bruen, Brian K and Docteur, Elizabeth and Lopert, Ruth and Cohen, Joshua and DiMasi, Joseph and Dor, Avi and Neumann, Peter and DeSantis, Regina and Shih, Chuck},
}

{"_id":"nPFYk4zavLsmWDtsZ","bibbaseid":"bruen-docteur-lopert-cohen-dimasi-dor-neumann-desantis-etal-theimpactofreimbursementpoliciesandpracticesonhealthcaretechnologyinnovation","author_short":["Bruen, B. K","Docteur, E.","Lopert, R.","Cohen, J.","DiMasi, J.","Dor, A.","Neumann, P.","DeSantis, R.","Shih, C."],"bibdata":{"bibtype":"article","type":"article","title":"The Impact of Reimbursement Policies and Practices on Healthcare Technology Innovation","abstract":"Methods & Analytical FrameWork................................................................................................................ 4 Defining Key Terms ................................................................................................................................... 4 Development of an Analytic Framework .................................................................................................. 8 Analysis of Key Characteristics of Reimbursement Methods ................................................................... 8 Expert Consultations................................................................................................................................. 9 Case Studies .............................................................................................................................................. 9 Results......................................................................................................................................................... 11 Tracing the Link from Reimbursement to Innovation............................................................................. 12 Key Characteristics of Reimbursement Methods ................................................................................... 13 How Reimbursement Characteristics Affect Components of ROI and Incentives to Innovate .............. 22 The Reimbursement Decision-Making Process................................................................................... 22 Product Categorization and Differentiation........................................................................................ 29 Method of Payment............................................................................................................................ 36 Defining the Payment Amount ........................................................................................................... 41 Patient Cost Sharing............................................................................................................................ 47 Conclusion................................................................................................................................................... 54 Suggestions for Future Research ........................................................................................................ 57 Appendix A: A Standard Reimbursement Decision-Making Process .......................................................... 60 Appendix B: hi HealthInnovations Case Study............................................................................................ 62 Appendix C: Premera Value-Based Formulary Case Study ......................................................................... 72 Appendix D: NICE (UK) Performance-Based Reimbursement for Velcade® ............................................... 83 Appendix E: Expert Panelists....................................................................................................................... 93","language":"en","author":[{"propositions":[],"lastnames":["Bruen"],"firstnames":["Brian","K"],"suffixes":[]},{"propositions":[],"lastnames":["Docteur"],"firstnames":["Elizabeth"],"suffixes":[]},{"propositions":[],"lastnames":["Lopert"],"firstnames":["Ruth"],"suffixes":[]},{"propositions":[],"lastnames":["Cohen"],"firstnames":["Joshua"],"suffixes":[]},{"propositions":[],"lastnames":["DiMasi"],"firstnames":["Joseph"],"suffixes":[]},{"propositions":[],"lastnames":["Dor"],"firstnames":["Avi"],"suffixes":[]},{"propositions":[],"lastnames":["Neumann"],"firstnames":["Peter"],"suffixes":[]},{"propositions":[],"lastnames":["DeSantis"],"firstnames":["Regina"],"suffixes":[]},{"propositions":[],"lastnames":["Shih"],"firstnames":["Chuck"],"suffixes":[]}],"bibtex":"@article{bruen_impact_nodate,\n\ttitle = {The {Impact} of {Reimbursement} {Policies} and {Practices} on {Healthcare} {Technology} {Innovation}},\n\tabstract = {Methods \\& Analytical FrameWork................................................................................................................ 4 Defining Key Terms ................................................................................................................................... 4 Development of an Analytic Framework .................................................................................................. 8 Analysis of Key Characteristics of Reimbursement Methods ................................................................... 8 Expert Consultations................................................................................................................................. 9 Case Studies .............................................................................................................................................. 9\nResults......................................................................................................................................................... 11 Tracing the Link from Reimbursement to Innovation............................................................................. 12 Key Characteristics of Reimbursement Methods ................................................................................... 13 How Reimbursement Characteristics Affect Components of ROI and Incentives to Innovate .............. 22 The Reimbursement Decision-Making Process................................................................................... 22 Product Categorization and Differentiation........................................................................................ 29 Method of Payment............................................................................................................................ 36 Defining the Payment Amount ........................................................................................................... 41 Patient Cost Sharing............................................................................................................................ 47\nConclusion................................................................................................................................................... 54 Suggestions for Future Research ........................................................................................................ 57 Appendix A: A Standard Reimbursement Decision-Making Process .......................................................... 60 Appendix B: hi HealthInnovations Case Study............................................................................................ 62 Appendix C: Premera Value-Based Formulary Case Study ......................................................................... 72 Appendix D: NICE (UK) Performance-Based Reimbursement for Velcade® ............................................... 83 Appendix E: Expert Panelists....................................................................................................................... 93},\n\tlanguage = {en},\n\tauthor = {Bruen, Brian K and Docteur, Elizabeth and Lopert, Ruth and Cohen, Joshua and DiMasi, Joseph and Dor, Avi and Neumann, Peter and DeSantis, Regina and Shih, Chuck},\n}\n\n\n\n","author_short":["Bruen, B. K","Docteur, E.","Lopert, R.","Cohen, J.","DiMasi, J.","Dor, A.","Neumann, P.","DeSantis, R.","Shih, C."],"key":"bruen_impact_nodate","id":"bruen_impact_nodate","bibbaseid":"bruen-docteur-lopert-cohen-dimasi-dor-neumann-desantis-etal-theimpactofreimbursementpoliciesandpracticesonhealthcaretechnologyinnovation","role":"author","urls":{},"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bibbase.org/zotero/XiangrongLu","dataSources":["qNt3P6iaAg3Ryeo4C"],"keywords":[],"search_terms":["impact","reimbursement","policies","practices","healthcare","technology","innovation","bruen","docteur","lopert","cohen","dimasi","dor","neumann","desantis","shih"],"title":"The Impact of Reimbursement Policies and Practices on Healthcare Technology Innovation","year":null}